🟢 Pacific Biosciences is trading 7.94% up today following positive late-stage melanoma cancer-vaccine results

Pacific Biosciences is trading 7.94% up at $1.22 as biotech shares rally following positive late-stage melanoma cancer-vaccine results from Moderna and Merck.

• The sector catalyst is lifting broader biotech sentiment.
• No fresh Pacific Biosciences-specific announcement was identified for August 19, 2026.
• Its latest major updates were the August 5 CEO transition and second-quarter results.